Just a note-I failed on both Gleevec and Tasigna-doing good on Sprycell. In a message dated 12/10/2009 4:50:33 A.M. Pacific Standard Time, [email protected] writes:
The Novartis-financed study tested Tasigna against Gleevec in 846 patients who were newly diagnosed with a form of blood cancer called chronic myeloid leukemia. After a year of treatment, a blood test measuring the presence of the disease showed a major drop in about twice as many of the patients who took Tasigna, according to results of the study presented Tuesday at the American Society of Hematology's annual meeting in New Orleans. -- [CMLHope] A support group of http://cmlhope.com ------------------------------------------------- You received this message because you are subscribed to the Google Groups "CMLHope" group. To post to this group, send email to [email protected] To unsubscribe from this group, send email to [email protected] For more options, visit this group at http://groups.google.com/group/CMLHope
